Navigation Links
URAC Invites Health Management Industry, Public for Comments on Changes to Its Core Accreditation Standards
Date:2/28/2008

Changes in standards support Department of Health and Human Services' "Four Cornerstones" for health care improvement

WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- Today URAC called for comments on major revisions to its Core Accreditation standards. The Core standards are the foundation of URAC accreditation, addressing key organizational functions within health care organization such as staff qualifications, oversight of delegated activities, quality management and consumer protection.

(LOGO: http://www.newscom.com/cgi-bin/prnh/20030501/URACLOGO)

URAC is seeking input from any interested parties, including purchasers, policy makers, consumers, health care management organizations and health plans. The deadline for public comment is April 14, 2008.

URAC's Health Standards Committee reviewed and revised the standards now open for public comment. Changes to Core Version 2.1 accreditation standards include assigning weights to each standard element according to refined weight categories, a reorganization of the standards designed to clarify which standards apply to various types of applicants, and a focus on protecting and empowering the consumer through a new standard emphasizing health care literacy.

New policy concepts are introduced in the Core standards to address key issues in health care including two of the U.S. Department of Health and Human Services "Four Cornerstones" for health care improvement. Quality standards require the use of national quality measures, where they exist, as benchmarks for their quality improvement projects. Interoperable health information technology is introduced as well to promote greater efficiency in the health care system.

"The Core Standards define key and foundational principles upon which a quality system is based," said Douglas Metz, DC, chairman of URAC's Health Standards Committee a
'/>"/>

SOURCE URAC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. USDA invites industry to partner with MyPyramid
2. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
3. Malaria Community Applauds Clintons $1 Billion a Year Pledge; Invites Other Candidates to Make Malaria Commitments
4. American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area
5. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference
6. Alexion Pharmaceuticals Invites You to Participate in its Third Quarter 2007 Results Conference Call and Web Cast
7. Par Invites Public to Listen to Webcast of its September 28 Analysts Meeting
8. Help Raise Awareness of Obesity - Annual Walk From Obesity Invites Participants to Join a Walk in Their Local Area
9. Dole Invites Consumers to Show Their Wild Side!
10. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
11. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...earchers from the Columbia University Medical Cent...an affect the gums much earlier than anticipated. ...th and Naomi Berrie Diabetes Center also collabora...e February issue of Diabetes Care. "Our research i...
...ection from the Human Immunodeficiency Virus (HIV)...ding to US based scientists. The disease is report...world since 1981. //The lab tests of the chemical ...s's ability to infect cells, according to BBC News...
... life expectancy across the world is increasing, a...he UK who are in their 30s will live to see their ... the population of centenarians is expected to soa... 1.2 million by 2074 in Britain, according to the ...
... possibility of cavity problems in infants can be ...tment per year. This particular treatment does not...und is directly brushed into the teeth. //The Jour...gs which say that children who did not receive the...
Other Medicine News:Health News:Gum Disease Affects Diabetic Children Earlier Than Anticipated 2
(Date:9/5/2008)... SOUTH SAN FRANCISCO, Calif., Sept. 5 /PRNewswi...mpany focused on small molecule LFA-1 inhibitors,t...euticals, Inc. (Nasdaq:,SNSS) today announced SARc...small molecule LFA-1 product candidate for T-cell ...entered into a license agreement providing,SARcode...
(Date:9/4/2008)... SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCa...y announced that the pivotal clinical study of,Pol...s partner, Chemische,Fabrik KREUSSLER & Co. GmbH (...point and has been submitted to FDA as part of a N...l clinical study, named the EASI (Efficacy and saf...
(Date:9/4/2008)... Pivotal Study Seeks to Enroll 750 Women at More T.... 4 /- QuatRx Pharmaceuticals, a,priv...velopment and,commercialization of compounds to tr...ers, today announced that it has initiated a secon... tablets), the company,s,estrogen-free oral therap...
(Date:9/4/2008)... Data Announcements Remain on Schedule with Two ... Clinical Data Release in November 2008, BRIDGEWA...ceuticals,Inc., a specialty pharmaceutical compan...etabolic disease, today announced the appointment ... of directors., Peter Garrambone,s career include...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2Chemotherapy with gemcitabine delays progression of operable pancreatic cancer 2181 1Chemotherapy with gemcitabine delays progression of operable pancreatic cancer 2181 2Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 1Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 2Kaiser Permanente Study Shows Alcohol Consumption No Matter Beverage Type Linked to Breast Cancer Risk 2172 1Kaiser Permanente Study Shows Alcohol Consumption No Matter Beverage Type Linked to Breast Cancer Risk 2172 2Kaiser Permanente Study Shows Alcohol Consumption No Matter Beverage Type Linked to Breast Cancer Risk 2172 3Kaiser Permanente Study Shows Alcohol Consumption No Matter Beverage Type Linked to Breast Cancer Risk 2172 4Eating AGE Rich Foods Causes Dysfunction Linked to Heart Disease 2168 1Eating AGE Rich Foods Causes Dysfunction Linked to Heart Disease 2168 2
...ity of Abstracts Reflects Continued Growth of Eisa...May 31, 2007 /PRNewswire/ -- Eisai,announced today...ut,their oncology pipeline compounds have been acc...Clinical Oncology (ASCO),annual meeting. ASCO take...stracts reveal a growing and diverse oncology clin...
...-(BUSINESS WIRE)--May 31, 2007 - Hemispherx Biopha... engaged in the clinical,development and manufactu...ts, announced today a new scientific report featur...feron-LDO in,combating highly pathogenic avian inf...DO is a low-dose experimental oral formulation,of ...
Other Medicine Technology:Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 2Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 3Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 4Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 2Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 3Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 4
Full Handle Laseredge Implant Blade Knife, 6.0 pilot tip. Blade dimension: 16.5 mm x 6.0 mm x 4.2 mm x 2.4 mm.
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip. Blade dimension: 14.4 mm x 3.2 mm x 3.8 mm x 1.65 mm.
Full Handle Laseredge Implant Blade Knife, 5.2 mm straight. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm.
Full Handle Laseredge Crescent Blade Knife, angled bevel down. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm.
Medicine Products: